PBYI- Puma Biotechnology, Inc.

Name: Puma Biotechnology, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Puma Biotechnology, Inc. (PBYI) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. PBYI is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Auerbach Alan H	7.26M	$58.96M	-
CFO	Nougues Maximo F	240.0K	$1.95M	-
Other	Hunt Douglas M	205.3K	$1.67M	-
Dir	Miller Michael Patrick	54.0K	$438.5K	-

Activity

Buys and sells only

Transactions

10 filings · page 7

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 2, 2022	Wong Alvin F56	Chief Scientific Officer	Sell	514	$4.50	$2,311.87	-0.9%	-10.6%	-15.7%
Nov 2, 2022	Hunt Douglas M62	See Remarks	Sell	429	$2.25	$965.25	-0.6%	+99.1%	+15.3%
Nov 2, 2022	Auerbach Alan H62	President And CEO	Sell	1,242	$2.25	$2,794.50	-	+99.1%	+15.3%
Nov 2, 2022	Nougues Maximo F61	Chief Financial Officer	Sell	163	$2.25	$366.75	-0.1%	+99.1%	+15.3%
Oct 3, 2022	Nougues Maximo F61	Chief Financial Officer	Sell	165	$2.34	$385.34	-0.1%	+72.8%	+4.2%
Oct 3, 2022	Hunt Douglas M62	See Remarks	Sell	435	$2.34	$1,015.90	-0.6%	+72.8%	+4.2%
Oct 3, 2022	Auerbach Alan H62	President And CEO	Sell	1,260	$2.34	$2,942.60	-	+72.8%	+4.2%
Sep 2, 2022	Nougues Maximo F61	Chief Financial Officer	Sell	164	$2.59	$424.69	-0.1%	+76.7%	+43.4%
Sep 2, 2022	Hunt Douglas M62	See Remarks	Sell	433	$2.59	$1,121.30	-0.6%	+76.7%	+43.4%
Sep 2, 2022	Auerbach Alan H62	President And CEO	Sell	1,254	$2.59	$3,247.36	-	+76.7%	+43.4%

← PrevPage 7Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC